CASADEI, BEATRICE
CASADEI, BEATRICE
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study
2020 Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi, Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years
2016 Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia; Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine
2022 Filippi, F; Baraldi, C; Zinzani, P L; Casadei, B; Pileri, A
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies
2019 Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient
2022 Lolli, Ginevra; Ursi, Margherita; Dicataldo, Michele; Casadei, Beatrice; Storci, Gianluca; Argnani, Lisa; Bonifazi, Francesca; Zinzani, Pier Luigi
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
2021 Merryman R.W.; Castagna L.; Giordano L.; Ho V.T.; Corradini P.; Guidetti A.; Casadei B.; Bond D.A.; Jaglowski S.; Spinner M.A.; Arai S.; Lowsky R.; Shah G.L.; Perales M.-A.; De Colella J.M.S.; Blaise D.; Herrera A.F.; Shouse G.; Spilleboudt C.; Ansell S.M.; Nieto Y.; Badar T.; Hamadani M.; Feldman T.A.; Dahncke L.; Singh A.K.; McGuirk J.P.; Nishihori T.; Chavez J.; Serritella A.V.; Kline J.; Mohty M.; Dulery R.; Stamatoulas A.; Houot R.; Manson G.; Moles-Moreau M.-P.; Orvain C.; Bouabdallah K.; Modi D.; Ramchandren R.; Lekakis L.; Beitinjaneh A.; Frigault M.J.; Chen Y.-B.; Lynch R.C.; Smith S.D.; Rao U.; Byrne M.; Romancik J.T.; Cohen J.B.; Nathan S.; Phillips T.; Joyce R.M.; Rahimian M.; Bashey A.; Ballard H.J.; Svoboda J.; Torri V.; Sollini M.; De Philippis C.; Magagnoli M.; Santoro A.; Armand P.; Zinzani P.L.; Carlo-Stella C.
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients
2013 Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
2022 Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Coppola P.E.; Zinzani P.L.
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients
2020 Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L.
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study
2013 Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M.
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy
2022 De Matteis, Serena; Casadei, Beatrice; Lolli, Ginevra; Dicataldo, Michele; Barbato, Francesco; Dan, Elisa; Paccagnella, Andrea; Sinigaglia, Barbara; Bertuzzi, Clara; Arcari, Annalisa; Zazzeroni, Luca; Bernuzzi, Patrizia; Laprovitera, Noemi; Storci, Gianluca; Bertuccio, Salvatore Nicola; Ferracin, Manuela; Bonafe, Massimiliano; Zinzani, Pier Luigi; Bonifazi, Francesca
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report
2021 Lolli G.; Casadei B.; Argnani L.; Pileri A.; Pellegrini C.; Zinzani P.L.
Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma.
2013 Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta MR; Narducci R; Argnani L; Zinzani PL.
Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports.
2013 Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
2015 Derenzini, Enrico; Agostinelli, Claudio; Imbrogno, Enrica; Iacobucci, Ilaria; Casadei, Beatrice; Brighenti, Elisa; Righi, Simona; Fuligni, Fabio; Ghelli Luserna Di Rorà, Andrea; Ferrari, Anna; Martinelli, Giovanni; Pileri, Stefano; Zinzani, Pier Luigi
Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue (Annals of Oncology (2018) 29 (2363-2370) DOI: 10.1093/annonc/mdy450)
2019 Ciavarella S.; Vegliante M.C.; Fabbri M.; De Summa S.; Melle F.; Motta G.; De Iuliis V.; Opinto G.; Enjuanes A.; Rega S.; Gulino A.; Agostinelli C.; Scattone A.; Tommasi S.; Mangia A.; Mele F.; Simone G.; Zito A.F.; Ingravallo G.; Vitolo U.; Chiappella A.; Tarella C.; Gianni A.M.; Rambaldi A.; Zinzani P.L.; Casadei B.; Derenzini E.; Loseto G.; Pileri A.; Tabanelli V.; Fiori S.; Rivas-Delgado A.; Lopez-Guillermo A.; Venesio T.; Sapino A.; Campo E.; Tripodo C.; Guarini A.; Pileri S.A.
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue
2018 Ciavarella, S; Vegliante, M C; Fabbri, M; De Summa, S; Melle, F; Motta, G; De Iuliis, V; Opinto, G; Enjuanes, A; Rega, S; Gulino, A; Agostinelli, C; Scattone, A; Tommasi, S; Mangia, A; Mele, F; Simone, G; Zito, A F; Ingravallo, G; Vitolo, U; Chiappella, A; Tarella, C; Gianni, A M; Rambaldi, A; Zinzani, P L; Casadei, B; Derenzini, E; Loseto, G; Pileri, A; Tabanelli, V; Fiori, S; Rivas-Delgado, A; López-Guillermo, A; Venesio, T; Sapino, A; Campo, E; Tripodo, C; Guarini, A; Pileri, S A
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia
2022 Broccoli A.; Terragna C.; Nanni L.; Martello M.; Armuzzi S.; Agostinelli C.; Morigi A.; Casadei B.; Pellegrini C.; Stefoni V.; Sabattini E.; Argnani L.; Zinzani P.L.
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia
2022 Broccoli A.; Terragna C.; Nanni L.; Martello M.; Armuzzi S.; Agostinelli C.; Morigi A.; Casadei B.; Pellegrini C.; Stefoni V.; Sabattini E.; Argnani L.; Zinzani P.L.
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
2022 Rossi A.; Orecchioni S.; Falvo P.; Tabanelli V.; Baiardi E.; Agostinelli C.; Melle F.; Motta G.; Calleri A.; Fiori S.; Corsini C.; Casadei B.; Mazzara S.; Vitolo U.; Bertolini F.; Zinzani P.L.; Alcalay M.; Pelicci P.G.; Pileri S.; Tarella C.; Derenzini E.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| (90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study | Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi..., Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L | 2020-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| 90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years | Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia;... Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi | 2016-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | cam4.684.pdf |
| A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine | Filippi, F; Baraldi, C; Zinzani, P L; Casadei, B; Pileri, A | 2022-01-01 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | - | 1.01 Articolo in rivista | - |
| A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies | Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Argnani,... Lisa; Cavo, Michele; Zinzani, Pier Luigi | 2019-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient | Lolli, Ginevra; Ursi, Margherita; Dicataldo, Michele; Casadei, Beatrice; Storci, Gianluca; Argnan...i, Lisa; Bonifazi, Francesca; Zinzani, Pier Luigi | 2022-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma | Merryman R.W.; Castagna L.; Giordano L.; Ho V.T.; Corradini P.; Guidetti A.; Casadei B.; Bond D.A....; Jaglowski S.; Spinner M.A.; Arai S.; Lowsky R.; Shah G.L.; Perales M.-A.; De Colella J.M.S.; Blaise D.; Herrera A.F.; Shouse G.; Spilleboudt C.; Ansell S.M.; Nieto Y.; Badar T.; Hamadani M.; Feldman T.A.; Dahncke L.; Singh A.K.; McGuirk J.P.; Nishihori T.; Chavez J.; Serritella A.V.; Kline J.; Mohty M.; Dulery R.; Stamatoulas A.; Houot R.; Manson G.; Moles-Moreau M.-P.; Orvain C.; Bouabdallah K.; Modi D.; Ramchandren R.; Lekakis L.; Beitinjaneh A.; Frigault M.J.; Chen Y.-B.; Lynch R.C.; Smith S.D.; Rao U.; Byrne M.; Romancik J.T.; Cohen J.B.; Nathan S.; Phillips T.; Joyce R.M.; Rahimian M.; Bashey A.; Ballard H.J.; Svoboda J.; Torri V.; Sollini M.; De Philippis C.; Magagnoli M.; Santoro A.; Armand P.; Zinzani P.L.; Carlo-Stella C. | 2021-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience | Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; ...Nanni L.; Coppola P.E.; Zinzani P.L. | 2022-01-01 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | Stefoni2022_Article_BEGEVSalvageRegimenInRelapsedR.pdf |
| Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients | Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; ...Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L. | 2020-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study | Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Pucc...ini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy | De Matteis, Serena; Casadei, Beatrice; Lolli, Ginevra; Dicataldo, Michele; Barbato, Francesco; Da...n, Elisa; Paccagnella, Andrea; Sinigaglia, Barbara; Bertuzzi, Clara; Arcari, Annalisa; Zazzeroni, Luca; Bernuzzi, Patrizia; Laprovitera, Noemi; Storci, Gianluca; Bertuccio, Salvatore Nicola; Ferracin, Manuela; Bonafe, Massimiliano; Zinzani, Pier Luigi; Bonifazi, Francesca | 2022-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | 2022_DeMatteis_fimmu-13-994731.pdf |
| Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report | Lolli G.; Casadei B.; Argnani L.; Pileri A.; Pellegrini C.; Zinzani P.L. | 2021-01-01 | ACTA HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma. | Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta ...MR; Narducci R; Argnani L; Zinzani PL. | 2013-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports. | Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL | 2013-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma | Derenzini, Enrico; Agostinelli, Claudio; Imbrogno, Enrica; Iacobucci, Ilaria; Casadei, Beatrice; ...Brighenti, Elisa; Righi, Simona; Fuligni, Fabio; Ghelli Luserna Di Rorà, Andrea; Ferrari, Anna; Martinelli, Giovanni; Pileri, Stefano; Zinzani, Pier Luigi | 2015-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue (Annals of Oncology (2018) 29 (2363-2370) DOI: 10.1093/annonc/mdy450) | Ciavarella S.; Vegliante M.C.; Fabbri M.; De Summa S.; Melle F.; Motta G.; De Iuliis V.; Opinto G....; Enjuanes A.; Rega S.; Gulino A.; Agostinelli C.; Scattone A.; Tommasi S.; Mangia A.; Mele F.; Simone G.; Zito A.F.; Ingravallo G.; Vitolo U.; Chiappella A.; Tarella C.; Gianni A.M.; Rambaldi A.; Zinzani P.L.; Casadei B.; Derenzini E.; Loseto G.; Pileri A.; Tabanelli V.; Fiori S.; Rivas-Delgado A.; Lopez-Guillermo A.; Venesio T.; Sapino A.; Campo E.; Tripodo C.; Guarini A.; Pileri S.A. | 2019-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue | Ciavarella, S; Vegliante, M C; Fabbri, M; De Summa, S; Melle, F; Motta, G; De Iuliis, V; Opinto, ...G; Enjuanes, A; Rega, S; Gulino, A; Agostinelli, C; Scattone, A; Tommasi, S; Mangia, A; Mele, F; Simone, G; Zito, A F; Ingravallo, G; Vitolo, U; Chiappella, A; Tarella, C; Gianni, A M; Rambaldi, A; Zinzani, P L; Casadei, B; Derenzini, E; Loseto, G; Pileri, A; Tabanelli, V; Fiori, S; Rivas-Delgado, A; López-Guillermo, A; Venesio, T; Sapino, A; Campo, E; Tripodo, C; Guarini, A; Pileri, S A | 2018-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | 1-s2.0-S0923753419342371-main.pdf |
| Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia | Broccoli A.; Terragna C.; Nanni L.; Martello M.; Armuzzi S.; Agostinelli C.; Morigi A.; Casadei B....; Pellegrini C.; Stefoni V.; Sabattini E.; Argnani L.; Zinzani P.L. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia | Broccoli A.; Terragna C.; Nanni L.; Martello M.; Armuzzi S.; Agostinelli C.; Morigi A.; Casadei B....; Pellegrini C.; Stefoni V.; Sabattini E.; Argnani L.; Zinzani P.L. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma | Rossi A.; Orecchioni S.; Falvo P.; Tabanelli V.; Baiardi E.; Agostinelli C.; Melle F.; Motta G.; ...Calleri A.; Fiori S.; Corsini C.; Casadei B.; Mazzara S.; Vitolo U.; Bertolini F.; Zinzani P.L.; Alcalay M.; Pelicci P.G.; Pileri S.; Tarella C.; Derenzini E. | 2022-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |